Infectious Disease
Fever workup by site and host. Sepsis is the drumbeat emergency. Know your empiric antibiotics and when to narrow.
Chief complaints
Vignettes enter through one of these doors. Each complaint lays out the full differential, marks the can't-miss diagnoses, and tells you the next right action for each.
Fever workup
Source hunt by history, exam, and targeted testing. Host matters, immunocompromised differs.
Always: full exam (skin, joints, lines, lungs, abdomen, GU, CNS), urinalysis, blood cultures, CBC, CXR. Travel history, exposures, sick contacts. Immunocompromised broaden to fungal, viral, atypical.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Sepsis | SIRS + suspected infection. Hypotension, tachycardia, altered mental status, organ dysfunction. | Sepsis bundle within 1 hour: cultures, lactate, broad antibiotics, 30 mL/kg crystalloid if lactate ≥ 4 or hypotension |
| Neutropenic fever | ANC < 500 with fever ≥ 38.3. Recent chemo. | Blood cultures × 2, CXR, UA · empiric cefepime or pip-tazo · add vanc if line, mucositis, hypotension |
| Meningitis | Fever + headache + neck stiffness + AMS. | Empiric antibiotics first, then LP · CT before LP if focal deficit, AMS, papilledema, immunocompromised |
| Endocarditis | Fever + new murmur or vascular phenomena (Janeway, Osler, Roth, splinter). | 3 sets of blood cultures from separate sites, different times · TTE (TEE if high suspicion or prosthetic) · Duke criteria |
| UTI / pyelonephritis | Dysuria, frequency, urgency, suprapubic pain. Pyelo: flank pain, fever. | UA · urine culture · antibiotics |
| Pneumonia | Cough, sputum, focal crackles, infiltrate. | CXR · sputum · blood cultures · antibiotics per CURB-65 |
| Skin/soft tissue | Redness, warmth, tenderness, abscess. | Clinical · I&D for abscess · cover MRSA for purulent |
Sepsis
Life-threatening organ dysfunction from dysregulated host response to infection. Time-sensitive bundle.
Identify source. Give antibiotics within 1 hour (empiric based on suspected source). Fluids (30 mL/kg if hypotension or lactate ≥ 4). Pressors if not responsive to fluids. Source control (drain abscesses, remove lines, debride).
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Septic shock | Sepsis + persistent hypotension requiring pressors and lactate > 2 despite fluids. | Norepinephrine first (target MAP ≥ 65) · add vasopressin · steroids if refractory |
| Source-specific sepsis | Depends on source: lung (pneumonia), urine (UTI), abdomen, skin, CNS, blood (line/endocarditis). | Targeted antibiotics + source control |
STIs
Screen by risk factors. Empiric treatment covers gonorrhea + chlamydia for urethritis or cervicitis.
Urethritis/cervicitis: NAAT for gonorrhea and chlamydia, treat empirically. GUD: HSV most common, then syphilis. Serology and PCR.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Gonorrhea | Purulent urethritis or cervicitis. Can disseminate (tenosynovitis, dermatitis, polyarthralgia → septic arthritis). | Ceftriaxone 500 mg IM (1 g if ≥ 150 kg) · treat chlamydia empirically unless ruled out |
| Chlamydia | Urethritis (men), cervicitis or asymptomatic (women). LGV with bubos. | Doxycycline 100 mg BID × 7 days (azithro if pregnant) |
| Syphilis | Primary: painless chancre. Secondary: rash (palms/soles), condyloma lata, constitutional. Latent. Tertiary: gumma, CV, neuro. | RPR/VDRL, then FTA-ABS. Benzathine PCN G 2.4 million U IM (single for early, weekly × 3 for late). Neurosyphilis: IV PCN × 10–14 days |
| HSV | Painful vesicular lesions, recurrent. | PCR · acyclovir, valacyclovir, or famciclovir |
| HIV | Acute: fever, rash, lymphadenopathy, pharyngitis (mono-like). Chronic: opportunistic infections. | 4th-gen antigen/antibody · viral load · CD4 count · start ART |
| Trichomoniasis | Frothy yellow-green discharge, strawberry cervix. | Metronidazole 2 g single dose (or 500 BID × 7 days) · treat partners |
| Bacterial vaginosis | Thin gray discharge, fishy odor, clue cells, vaginal pH > 4.5. Not technically an STI. | Metronidazole or clindamycin |
Disease deep dives
Once you've identified the likely diagnosis from the chief complaint, these pages give you the presentation, workup, management, and exam pearls in depth.
Sepsis
Organ dysfunction from infection. Early recognition and aggressive treatment save lives.
Fever, tachycardia, tachypnea, hypotension, AMS, oliguria. Source-specific features.
- Blood cultures × 2. Before antibiotics if possible, from separate sites.
- Lactate. Hypoperfusion marker. Trend.
- Source-specific cultures. Urine, sputum, wound, CSF.
- Imaging. CXR, abdominal imaging based on suspicion.
- Antibiotics within 1 hour. Broad empiric: vancomycin + (pip-tazo OR cefepime OR meropenem). Narrow once cultures return.
- IV fluids. 30 mL/kg crystalloid bolus if hypotension or lactate ≥ 4.
- Vasopressors. Norepinephrine first (target MAP ≥ 65). Add vasopressin. Epinephrine if refractory.
- Steroids. Hydrocortisone 200 mg/day for refractory septic shock on pressors.
- Source control. Drain abscesses, remove infected lines, debride necrotic tissue, surgery for perforation.
Infective Endocarditis
Duke criteria. IVDU gets right-sided (tricuspid). Dental procedures can seed. Prosthetic valves are their own category.
Fever, new murmur, constitutional symptoms. Vascular: Janeway lesions, splinter hemorrhages, Roth spots, Osler nodes. Emboli: stroke, renal infarct, splenic infarct.
- Blood cultures × 3. From separate sites, separated by time. Before antibiotics.
- Echo. TTE first; TEE if high suspicion, TTE negative, or prosthetic valve. TEE has much higher sensitivity.
- Duke criteria. Definite: 2 major, 1 major + 3 minor, or 5 minor. Major: persistent bacteremia with typical organism, endocardial involvement on echo. Minor: fever, predisposition, vascular/immunologic phenomena, microbiological evidence not meeting major.
- Empiric antibiotics. Native valve: vancomycin + ceftriaxone. Prosthetic valve: vancomycin + gentamicin + cefepime or rifampin. Tailor to cultures.
- Duration. 4–6 weeks IV. Based on organism, native vs prosthetic.
- Surgery indications. HF from valve dysfunction, uncontrolled infection, recurrent emboli, prosthetic valve dysfunction, paravalvular abscess, fungal endocarditis.
- Prophylaxis. Before dental procedures only for highest-risk: prosthetic valves, prior IE, congenital heart disease (certain types), cardiac transplant with valvulopathy. Amoxicillin 2 g.
HIV
Test every adult at least once. Start ART at diagnosis regardless of CD4. Prophylaxis by CD4.
Acute: fever, pharyngitis, lymphadenopathy, rash, mouth ulcers, myalgia (2–4 weeks post-exposure). Chronic: opportunistic infections, constitutional symptoms.
- 4th-generation Ag/Ab. Detects p24 antigen and antibodies. Positive 2–4 weeks after infection.
- Confirmation. HIV-1/2 antibody differentiation assay. If discordant, HIV RNA.
- Baseline. CD4, viral load, HLA-B*5701 (before abacavir), hep B/C, toxoplasma IgG, STI screen, TB screen, resistance genotype.
- ART at diagnosis. Start immediately. Preferred: INSTI-based regimens. Bictegravir/TAF/FTC (single pill). Dolutegravir + TAF/FTC or TDF/3TC.
- PCP prophylaxis. CD4 < 200: TMP-SMX.
- Toxoplasma prophylaxis. CD4 < 100 and Toxo IgG+: TMP-SMX.
- MAC prophylaxis. Rarely needed now with ART. CD4 < 50 if ART delayed: azithromycin.
- Monitoring. Viral load and CD4 every 3 months initially. Target undetectable viral load (< 50).
- Pre-exposure prophylaxis. Daily TDF/FTC or TAF/FTC for high-risk individuals.
- Post-exposure prophylaxis. Within 72 hours. Triple-drug regimen × 28 days.
Tuberculosis
Latent vs active. 4-drug RIPE for 2 months, then 2 drugs for 4 months. Test and treat contacts.
Active pulmonary: chronic cough, hemoptysis, night sweats, weight loss, fever. Extrapulmonary: any organ. Latent: positive PPD or IGRA without disease.
- PPD or IGRA. Latent screen. IGRA preferred if BCG vaccinated.
- Active disease. Sputum AFB × 3 (induction if needed), sputum NAAT, culture (gold standard but slow).
- CXR. Upper lobe cavitary in reactivation. Lower or mid lobe in primary. Miliary in disseminated.
- Latent TB. Isoniazid 9 months OR rifampin 4 months OR INH + rifapentine weekly × 12 (3HP).
- Active TB. RIPE for 2 months (rifampin, isoniazid, pyrazinamide, ethambutol), then RI for 4 months.
- DOT. Directly observed therapy recommended.
- Resistance. MDR (resistant to rifampin and INH), XDR (additional resistance). Longer, more toxic regimens.
- Public health. Report. Contact tracing. Respiratory isolation for smear-positive patients.
Cellulitis & SSTI
Purulent vs non-purulent drives coverage. Necrotizing fasciitis is a surgical emergency.
Erythema, warmth, swelling, tenderness. Fever variable. Necrotizing fasciitis: pain out of proportion, systemic toxicity, crepitus, bullae, skin anesthesia.
- Clinical. No imaging needed for simple cellulitis.
- Cultures. From abscess drainage if purulent. Blood cultures if systemic.
- Imaging. CT or MRI if deep infection or necrotizing fasciitis suspected.
- Non-purulent cellulitis. Strep coverage, cephalexin or cefazolin IV. Amoxicillin also an option.
- Purulent (abscess). Incision and drainage (primary). Antibiotics for large, systemic symptoms, immunocompromised, multiple sites. Cover MRSA: TMP-SMX, doxycycline, or clindamycin outpatient; vancomycin or linezolid inpatient.
- Necrotizing fasciitis. Emergent surgical debridement. Empiric vancomycin + pip-tazo + clindamycin (toxin suppression). Adjunctive IVIG for streptococcal toxic shock.